Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
BSTC > SEC Filings for BSTC > Form 8-K on 27-Mar-2013All Recent SEC Filings

Show all filings for BIOSPECIFICS TECHNOLOGIES CORP | Request a Trial to NEW EDGAR Online Pro

Form 8-K for BIOSPECIFICS TECHNOLOGIES CORP


27-Mar-2013

Other Events, Financial Statements and Exhibits


ITEM 8.01 OTHER EVENTS

On March 26, 2013, the Company announced positive statistically significant top-line data from the Phase IIa study for XIAFLEX for the potential treatment of frozen shoulder (adhesive capsulitis), which was conducted by BioSpecifics' strategic partner Auxilium Pharmaceuticals, Inc. (Auxilium).

A press release regarding the announcement is attached hereto as Exhibit 99.1.



ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

99.1 Press release dated March 26, 2013


  Add BSTC to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for BSTC - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.